Translational Mini-Review Series on Toll-like Receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders
- 5 January 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 147 (2) , 208-216
- https://doi.org/10.1111/j.1365-2249.2006.03296.x
Abstract
Summary: Characterization of the Toll-like receptor (TLR) family and associated signalling pathways provides a key molecular basis for our understanding of the relationship between exposure to microbial products and susceptibility to immune-mediated disorders. Indeed, ligation of TLR controls innate and adaptive immune responses by inducing synthesis of pro- as well as anti-inflammatory cytokines and activation of effector as well as regulatory lymphocytes. TLRs are therefore considered as major targets for the development of vaccine adjuvants, but also of new immunotherapies. Herein, we review the potential of TLR ligands as a novel class of pharmaceuticals for the prevention or treatment of allergic disorders.Keywords
This publication has 114 references indexed in Scilit:
- Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signalingJournal of Clinical Investigation, 2006
- Toll-like receptor 2 signaling modulates the functions of CD4+CD25+regulatory T cellsProceedings of the National Academy of Sciences, 2006
- Toll-like receptors—novel targets in allergic airway disease (probiotics, friends and relatives)European Journal of Pharmacology, 2006
- ENVIRONMENTAL FACTORS AND GENE-ENVIRONMENT INTERACTIONS IN THE AETIOLOGY OF ASTHMAClinical and Experimental Pharmacology and Physiology, 2006
- Potential role of interleukin-10-secreting regulatory T cells in allergy and asthmaNature Reviews Immunology, 2005
- Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivitiesJournal of Allergy and Clinical Immunology, 2004
- Immune Regulation by helminth parasites: cellular and molecular mechanismsNature Reviews Immunology, 2003
- The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: An historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic diseaseJournal of Allergy and Clinical Immunology, 2003
- The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-γ–producing cellsJournal of Allergy and Clinical Immunology, 2003
- Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe diseaseJournal of Allergy and Clinical Immunology, 2001